Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study (Q33385642)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study |
scientific article |
Statements
1 reference
Mapatumumab, an antibody targeting TRAIL-R1, in combination with paclitaxel and carboplatin in patients with advanced solid malignancies: results of a phase I and pharmacokinetic study (English)
1 reference
Margaret von Mehren
1 reference
D Ross Camidge
1 reference
Corey J Langer
1 reference
Stephen Leong
1 reference
Roger B Cohen
1 reference
Daniel L Gustafson
1 reference
Kristin Padavic
1 reference
Lia Gore
1 reference
Margaret Smith
1 reference
Laura Q Chow
1 reference
Cindy O'Bryant
1 reference
Sujatha Hariharan
1 reference
Sami Diab
1 reference
Norma Lynn Fox
1 reference
Renée Miceli
1 reference
S Gail Eckhardt
1 reference
1 reference
Identifiers
1 reference